Package 72205-184-60

{"route": ["ORAL"], "spl_id": "ea6e0136-75b2-4793-9500-04e6658a0a73", "openfda": {"nui": ["N0000000246", "N0000175889", "N0000190114", "N0000182137"], "upc": ["0372205184602", "0372205185302"], "unii": ["YO603Y8113"], "rxcui": ["670026", "1359269"], "spl_set_id": ["ea6e0136-75b2-4793-9500-04e6658a0a73"], "pharm_class_epc": ["Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Novadoz Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72205-184-60)", "package_ndc": "72205-184-60", "marketing_start_date": "20231129"}], "brand_name": "Darunavir", "product_id": "72205-184_ea6e0136-75b2-4793-9500-04e6658a0a73", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "72205-184", "generic_name": "Darunavir", "labeler_name": "Novadoz Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darunavir", "active_ingredients": [{"name": "DARUNAVIR", "strength": "600 mg/1"}], "application_number": "ANDA215389", "marketing_category": "ANDA", "marketing_start_date": "20231128", "listing_expiration_date": "20261231"}